Carole Gleeson

Carole Gleeson is a seasoned professional with extensive experience in the pharmaceutical and biotech industries, currently serving as the Sr. Director of New Product Planning & Portfolio Strategy at Ventus Therapeutics since April 2024. Prior to this role, Carole held several key positions, including Director of Business and Customer Insights at Rhythm Pharmaceuticals, where responsibilities included market assessments and insights for rare genetic diseases, and Director of Global Commercial Insights Lead at The Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on strategic market research for anti-FcRn programs. Carole's previous roles encompass leadership in competitive intelligence, new product planning, health economics, and commercial strategy across various organizations such as Momenta Pharmaceuticals, EMD Serono, and Alkermes. Carole holds an MBA from Babson College, a Master's degree from Harvard T.H. Chan School of Public Health, and a Bachelor's degree from Tufts University.